Anyone investing here has to believe they have found a mispriced/underpriced stock. If not, I would like to hear what brought them here and what is keeping them here.
This co went through a very tough year in 2017 as did many and it has shown it is not going away.
Maybe ATNX is buying in, maybe it isn't but at minimum the addition of Pedder (below) was a watershed moment. Since his coming on board, the company has transformed and is once again set up for success.
NEW YORK, Nov. 20, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that Simon Pedder, Ph.D., a scientist and pharmaceutical executive with a greater than 30-year career in drug development, has joined the Delcath Board of Directors effective November 14, 2017.
Anyone bashing this company at this point is using emotions of a bygone period that simply doesn't exist anymore. Anyone calling out Simpson is neglecting that she did her fiduciary responsibility well. She did what she had to do to ensure the company found the money to stay alive (as unpleasant as it was).
Straight FACTS: There are more positives than negatives currently and if stocks traded on the past... well they don't. They trade on what is expected.
All those upset at the payscale here most likely have never had to hire and keep top talent. I have. With the risk in volatility of the shareprice, I am certain they did what they did to retain the team. Typically options are used but at this time I am sure that wasn't enough.
Congrats to Jenny for 1) keeping the co alive, 2) on track to FDA approval, 3) keeping the team together 4) attracting Pedder to the Board 5) Getting their Patents back, 6) Getting the turnaround together as quickly as it has been happening.
I like what I see and Bashers will Bash. It's usually done to get cheaper shares which is BULLISH. A QUIET Message Board is more disconcerting.
